Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

8.270
-0.180-2.13%
Volume:6.89M
Turnover:56.55M
Market Cap:6.84B
PE:291.35
High:8.730
Open:8.600
Low:8.030
Close:8.450
Loading ...

HBM Holdings Ltd. Files Next Day Disclosure to HKEX Announcing Repurchase of 300,000 Shares at HKD 8.1738 Each

Reuters
·
Yesterday

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 1,900,000 Shares at HKD 8.6822 Each

Reuters
·
25 Jun

BRIEF-HBM Holdings Says Strategic Collaboration With Otsuka For HBM7020

Reuters
·
23 Jun

HBM Holdings Ltd. Enters Global Strategic Partnership with Otsuka Pharmaceutical for HBM7020 Development

Reuters
·
23 Jun

Hbm Holdings - Strategic Collaboration With Otsuka for Hbm7020

THOMSON REUTERS
·
23 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 200,000 Shares at HKD 7.7777 Each

Reuters
·
19 Jun

Hbm Holdings - on 17 June Co Repurchased HK$9 Mln Worth of Shares in Open Market

THOMSON REUTERS
·
18 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX Announcing Repurchase of 1,100,000 Shares at HKD 7.8443 Each

Reuters
·
17 Jun

BRIEF-HBM Holdings Says China National Intellectual Property Administration Issued Final Decision

Reuters
·
16 Jun

HBM Holdings Ltd. Successfully Defends Patent on Human Heavy Chain-Only Antibodies in China

Reuters
·
16 Jun

Hbm Holdings - China National Intellectual Property Administration Issued Final Decision Upholding Patent

THOMSON REUTERS
·
16 Jun

HBM Unit to License Antibody Technology to Visterra for Autoimmune Disease Treatments

MT Newswires Live
·
13 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX, Announces Repurchase of 500,000 Shares at HKD 4,336,060 Total

Reuters
·
13 Jun

BRIEF-HBM's Unit Enters Into License Agreement With Visterra

Reuters
·
12 Jun

Nona Biosciences, HBM Holdings Subsidiary, Enters License Agreement with Visterra for Biotherapeutic Advancement

Reuters
·
12 Jun

Hbm Holdings - Agreement to Advance Visterra's Next-Generation Biotherapeutic Pipeline for Immune-Mediated and Autoimmune Diseases

THOMSON REUTERS
·
12 Jun

Hbm Holdings - Unit Entered Into a License Agreement With Visterra, Inc

THOMSON REUTERS
·
12 Jun

HBM Holdings Ltd. Conducted Annual General Meeting

Reuters
·
11 Jun

HBM Holdings Ltd. Appoints Dr. Ian Yi Liu as Joint Company Secretary Amidst Management Changes

Reuters
·
10 Jun

HBM Holdings Ltd. Files Next Day Disclosure Return to HKEX Announcing Repurchase of 200,000 Shares at HKD 8.7394 Each

Reuters
·
04 Jun